Luciferase unleashed: Lighting the path to vaccine approval using a novel high-throughput chikungunya virus neutralization assay. [PDF]
Mendy J +8 more
europepmc +1 more source
Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development. [PDF]
Ma M, Li L, Sun H, Zhang X.
europepmc +1 more source
Primary infection with a Brazilian chikungunya virus isolate protects immunocompetent mice against detectable viremia following homologous rechallenge. [PDF]
da Silva NS +12 more
europepmc +1 more source
Overview of Chikungunya Virus Pathogenesis, Genome Variation, Epidemiology, and Control. [PDF]
Hamrahjoo M +4 more
europepmc +1 more source
Chikungunya virus infection in Italy: epidemiology, climate change implications and public health recommendations. [PDF]
Stefanizzi P +9 more
europepmc +1 more source
Chikungunya Virus: Unveiling Its Global Impact (2002-2024). [PDF]
Issrani R +7 more
europepmc +1 more source
AGPAT1 is a novel Chikungunya virus receptor on human cells. [PDF]
Basu B +5 more
europepmc +1 more source
Emetine dihydrochloride inhibits Chikungunya virus nsP2 helicase and shows robust antiviral activity in cells and mice. [PDF]
Sharma A +9 more
europepmc +1 more source
Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development - A Narrative Review. [PDF]
Zhao C +5 more
europepmc +1 more source
The SMARCA4-TMEM47 axis plays an essential role in chikungunya virus RNA replication. [PDF]
Fu YZ +8 more
europepmc +1 more source

